In addition, stronger phosphorylation of AKT, GSK-3β, mTOR and its downstream effectors was found in CD157-high versus CD157-low AML cell lines exposed to FCS (as source of ECM proteins) or to purified ECM proteins that bind CD15717. This evidence concerns the gene MTOR and acute myeloid leukemia.